Publications
2006
Males, S., R. R. Gad, G. Esmat, M. Said, C. Rekacewicz, K. Zalata, M. Abdel-Hamid, P. Bedossa, S. Pol, M. K. Mohamed et al. "
Serum alpha-fetoprotein (AFP) level predicts treatment outcome in chronic hepatitis C (ANRS 1211)."
JOURNAL OF CLINICAL VIROLOGY 36 (2006): S133.
Abstractn/a
Bakr, I., C. Rekacewicz, M. El Hosseiny, S. Ismail, M. El Daly, S. El-Kafrawy, G. Esmat, MA Hamid, M. K. Mohamed, and A. Fontanet. "
Higher clearance of hepatitis C virus infection in females compared with males."
GUT 55 (2006): 1183-1187.
Abstractn/a
2005
Esmat, G., A. Yosry, M. El-Serafi, A. Omar, W. Doss, A. Hosny, A. Ghali, H. Sabry, H. Attia, S. Kamel et al. "
Donor outcomes in right lobe adult living donor liver transplantation: Single-center experience in Egypt."
TRANSPLANTATION PROCEEDINGS 37 (2005): 3147-3150.
Abstractn/a
Nada, O., M. Abdel-Hamid, A. Ismail, L. El Shabrawy, KFS Sidhom, NMA El Badawy, FAA Ghazal, M. El Daly, S. El Kafrawy, G. Esmat et al. "
The role of the tumor necrosis factor (TNF) - Fas L and HCV in the development of hepatocellular carcinoma."
JOURNAL OF CLINICAL VIROLOGY 34 (2005): 140-146.
Abstractn/a
Yosry, A., W. Doss, A. Abdel-Bary, G. Esmat, M. El-Serafy, E. Omar, A. El-Tawil, A. Ghaly, A. Hosny, S. Rifaat et al. "
Hepatitis C virus genotype 4 recurrence in Egyptian living donor liver transplant recipients."
LIVER TRANSPLANTATION 11 (2005): C19.
Abstractn/a
El Makhzangy, H., C. Rekacewicz, SI Shouman, HN Mohamed, G. Esmat, A. Ismail, R. Rafaat, M. El Hosseiny, M. El Daly, S. El Kafrawy et al. "
Combined pegylated interferon alpha-2a and ribavirin in treatment of chronic hepatitis C in Egypt (ANRS 1211 trial)."
JOURNAL OF HEPATOLOGY 42 (2005): 203.
Abstractn/a
Elmakhzangy, HI, C. Rekacewicz, S. Shouman, HN Mohamed, G. Esmat, AA Mansour, A. Ismail, R. Rafaat, M. El Hosseiny, M. El Daly et al. "
Early predictors of sustained viral response (SVR) in chronic hepatitis C (Genotype 4) patients treated with pegylated interferon alpha-2a and ribavirin."
GASTROENTEROLOGY 128 (2005): A714.
Abstractn/a
Shouman, SI, M. K. Mohamed, G. Esmat, M. Attalla, H. Mansour, C. Rekacewicz, R. Rafaat, N. Sharaf, M. El Hosseiny, M. El Daly et al. "
Pegylated interfon for treatment of acute hepatitis C in Egypt (ANRS 1213 trial)."
JOURNAL OF HEPATOLOGY 42 (2005): 221.
Abstractn/a
2004
El-Raziky, M. S., M. El-Hawary, N. El-Koofy, S Okasha, M Isa, M. Kotb, K. Salama, G. Esmat, M. El-Raziky, A. M. Abouzied, and H. El-Karaksy. "
Hepatitis C virus infection in Egyptian children: single centre experience."
JOURNAL OF VIRAL HEPATITIS 11 (2004): 471-476.
Abstractn/a
2003
Esmat, GH, A. Abouzied, M. Abdel-Hamid, M. K. Mohamed, K. Zalata, MS El Raziky, SA Ismael, M. Said, A. Hasan, M. Anwar et al. "
Results of a randomized clinical trial of genotype-4 infected subjects when treated with standard or pegylated interferon alfa-2b in combination with ribavirin."
HEPATOLOGY 38 (2003): 314A-315A.
Abstractn/a
Esmat, G., M. K. Mohamed, MA Hamid, K. Zalata, H. Khatab, M. El Batanony, A. M. Abouzied, M. El Raziky, AM Shaheen, A. Ismail et al. "
The impact of steatosis on baseline characteristic and end of treatment response for chronic hepatitis (C) genotype 4 patients treated with interferon."
JOURNAL OF HEPATOLOGY 38 (2003): 139.
Abstractn/a
2002
Esmat, G., S. Zakaria, H. Khatab, M. Abdel-Hamid, M. Anwar, M. El-Razki, M. El-Daly, S. El-Kafrawy, A. Hasan, A. Shaheen et al. "
Impact of hepatitis C virus (HCV) genotype and viral load on the biochemical and histopathological liver profiles in Egyptian patients infected with HCV."
HEPATOLOGY 36 (2002): 535A.
Abstractn/a
Esmat, G., A. M. Abouzied, F. Abdel-Aziz, M. K. Mohamed, M. Abdel-Hamid, MS El Raziky, S. A. Ismail, KR Zalata, NN Mikhail, A. Fix et al. "
Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4."
HEPATOLOGY 36 (2002): 364A.
Abstractn/a
2001
2000
1994